STIM1 in the endoplasmic reticulum and CRACM1 in the plasma membrane are essential molecular components for controlling the store-operated CRAC current [1] [2] [3] [4] . CRACM1 proteins multimerize and bind STIM1 [5, 6] , and the combined overexpression of STIM1 and CRACM1 reconstitutes amplified CRAC currents [7] [8] [9] [10] . Mutations in CRACM1 determine the selectivity of CRAC currents, demonstrating that CRACM1 forms the CRAC channel's ion-selective pore [11, 5, 6 ], but the CRACM1 homologs CRACM2 and CRACM3 are less well characterized [7, 12] . Here, we show that both CRACM2 and CRACM3, when overexpressed in HEK293 cells stably expressing STIM1, potentiate I CRAC to current amplitudes 15-20 times larger than native I CRAC . A nonconducting mutation of CRACM1 (E106Q) acts as a dominant negative for all three CRACM homologs, suggesting that they can form heteromultimeric channel complexes. All three CRACM homologs exhibit distinct properties in terms of selectivity for Ca 2+ and Na + , differential pharmacological effects in response to 2-APB, and strikingly different feedback regulation by intracellular Ca
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STIM1 in the endoplasmic reticulum and CRACM1 in the plasma membrane are essential molecular components for controlling the store-operated CRAC current [1] [2] [3] [4] . CRACM1 proteins multimerize and bind STIM1 [5, 6] , and the combined overexpression of STIM1 and CRACM1 reconstitutes amplified CRAC currents [7] [8] [9] [10] . Mutations in CRACM1 determine the selectivity of CRAC currents, demonstrating that CRACM1 forms the CRAC channel's ion-selective pore [11, 5, 6] , but the CRACM1 homologs CRACM2 and CRACM3 are less well characterized [7, 12] . Here, we show that both CRACM2 and CRACM3, when overexpressed in HEK293 cells stably expressing STIM1, potentiate I CRAC to current amplitudes 15-20 times larger than native I CRAC . A nonconducting mutation of CRACM1 (E106Q) acts as a dominant negative for all three CRACM homologs, suggesting that they can form heteromultimeric channel complexes. All three CRACM homologs exhibit distinct properties in terms of selectivity for Ca 2+ and Na + , differential pharmacological effects in response to 2-APB, and strikingly different feedback regulation by intracellular Ca 2+ . Each of the CRAC channel proteins' specific functional features and the potential heteromerization provide for flexibility in shaping Ca 2+ signals, and their characteristic biophysical and pharmacological properties will aid in identifying CRAC-channel species in native cells that express them.
Results and Discussion
In many cell types, store-operated Ca 2+ entry represents the primary mechanism underlying long-lasting elevations in intracellular Ca 2+ , elevations that follow IP 3 mediated release of Ca 2+ from intracellular stores [13] [14] [15] [16] . Previous investigations have identified CRACM1 (or Orai1) as the calcium-release-activated calcium (CRAC) channels in the plasma membrane [3, 4] . There are three mammalian homologous CRAC channel proteins, CRACM1, CRACM2, and CRACM3, and all homologs are widely expressed at the mRNA level [12] .
CRACM Homologs Represent Store-Operated Channels
To assess the functional properties of CRACM proteins, we overexpressed all three CRACM species in HEK293 cells that stably overexpress STIM1 and measured CRAC currents in response to store depletion. Upon store depletion with IP 3 , all CRACM homologs produced large membrane currents ( Figure 1A ) with inwardly rectifying current-voltage (I/V) relationships characteristic of I CRAC ( Figure 1B ). Although our data substantiate that CRACM2 represents a store-operated channel, they are at variance with the reported inability of CRACM3 to increase store-operated Ca 2+ entry or CRAC currents [7] . We should note, however, that our own attempts with the commercial CRACM3 vector used by Mercer et al. also failed to produce enhanced CRAC currents when expressed in STIM1-expressing cells (data not shown). However, after subcloning the CRACM3 sequence into another vector (see the Experimental Procedures in the Supplemental Data online), we consistently observed significant CRACM3 currents.
The average current amplitudes of CRACM2 and CRACM3 at 280 mV were approximately 3-fold smaller than the corresponding amplitude of CRACM1, but they are still 15-to 20-fold larger than native CRAC currents in wild-type or STIM1-expressing HEK293 cells. The differences in amplitudes may be due to different expression levels but could also reflect differences in single-channel conductance or open probability. The activation kinetics of the CRACM homologs were distinctly different, with half-maximal activation times (6SEM) of CRACM1 at 35 6 7 s (n = 12), CRACM2 at 21 6 3 s (n = 8), and CRACM3 at 63 6 7 s (n = 9). These were unrelated to current magnitude because they were preserved when analyzing currents with matched amplitudes ( Figure 2 ) or at various [Ca 2+ ] i (see Figure 3) . We also examined whether CRACM currents were activated when preventing store refilling with 20 mM BAPTA in the pipette. Indeed, all three CRACM species produced CRAC-like currents with a characteristic delay that presumably reflects the time needed to deplete stores through leak pathways ( Figure S1A ). Under these conditions, CRAC currents developed with a similar time course, thus indicating that store depletion is likely to be the rate-limiting step for CRAC activation. The I/V relationships ( Figure S1B ) confirm that these currents also have the typical shape of CRAC currents. These results demonstrate that all three CRACM homologs can generate amplified store-operated CRAC currents and that they possess characteristic kinetics of activation, thus possibly indicating differences in the binding or interaction with STIM1.
CRACM Homologs Form Heteromeric Channels
Given that all three homologs produced store-operated channels and CRACM1 has been shown to form multimeric channel complexes, we used a nonconducting CRACM1 (E106Q) pore mutation that confers a dominant-negative phenotype on native CRAC channels [5] to assess whether CRACM1 can assemble into heteromeric channel complexes with CRACM2 and CRACM3. Figures 1A and 1C illustrate that the co-overexpression of CRACM1-E106Q in equal amounts with the three wild-type homologs essentially abolished CRAC currents, suggesting that the CRACM1 pore mutant indeed confers a dominant-negative effect. Coimmunoprecipitation experiments confirmed that CRACM1 can form stable heteromeric complexes with both of its homologs ( Figure 1D ).
CRACM Homologs Differ in Ca

2+
-Dependent Inactivation Native CRAC currents are regulated by [Ca 2+ ] i and subject to both fast and slow Ca 2+ -dependent inactivation [14, [17] [18] [19] [20] . Fast inactivation, occurring in the millisecond range, is believed to result from Ca 2+ binding to the channel itself [17, 18, 20] , whereas slow inactivation over tens of seconds may result from store refilling or regulatory mechanisms through cellular-feedback mechanisms on the channel [21, 22, 19] . Figure 2 illustrates IP 3 -induced CRAC currents with intracellular solutions that contained 10 mM EGTA, which is slower in chelating Ca 2+ than BAPTA and therefore less efficient in suppressing fast Ca 2+ -dependent inactivation [17, 20] . If sufficient Ca 2+ accumulates intracellularly, it may overpower the buffering capacity and then reveal slow Ca 2+ -dependent processes as well. CRAC currents were monitored continuously by voltage ramps spanning 2100 mV to +100 mV over 50 ms delivered at a rate of 0.5 Hz. After CRAC currents were fully activated, we delivered rectangular voltage pulses of 2 s duration and increasing hyperpolarizations so as to increase Ca 2+ entry. Figures 2A-2C illustrate that each hyperpolarizing pulse caused a fast drop in CRACM1-current amplitude that slowly, but not completely, recovered before the next pulse was delivered. The fast drop in current is due to fast inactivation, and the recovery is likely to be the net result of two opposing effects, recovery of channels from fast inactivation and slow inactivation proceeding over tens of seconds (see also Figure 3 ). In the case of CRACM1, the slow inactivation resulting from the five hyperpolarizing pulses resulted in w50% reduction in CRAC current over a period of w100 s. The same experimental protocol performed in cells expressing CRACM2 or CRACM3 revealed only fast inactivation of currents with no significant slow inactivation ( Figures 2B and 2C ). CRACM2 appeared fairly resistant to Ca 2+ -induced inactivation in general, with only a small component of fast inactivation, whereas CRACM3 displayed a much greater degree of fast inactivation. In both cases, recovery from fast inactivation was essentially complete within 20 s.
Figures 2D-2F illustrate averages of high-resolution CRAC currents produced by the hyperpolarizing pulses in (A)-(C), revealing the degree of fast Ca 2+ -dependent inactivation of the three homologs. CRACM3 currents exhibit a striking Ca 2+ -dependent inactivation that at 280 mV is characterized by a predominant exponential decay by w80% with a time constant of t = 17 ms and a very small slow component of t 2 = 130 ms. We confirmed that this dramatic inactivation of CRACM3 is in fact entirely due to Ca 2+ in experiments in which we delivered a hyperpolarizing voltage pulse to 280 mV in the presence of 10 mM Ca 2+ and after switching to DVF solution. This revealed a rapidly inactivating current while Ca 2+ was present, and a sustained, noninactivating current when divalent cations were absent ( Figure S2 ). CRACM2 exhibits moderately quick Ca 2+ -dependent inactivation, decaying with two time constants of t 1 = 80 ms and t 2 = 900 ms that both contribute in roughly equal amounts to total fast inactivation of w50%. CRACM1 exhibits complex behavior that may reflect three Ca 2+ -dependent feedback effects and therefore cannot be readily assessed quantitatively in terms of time constants. Presumably, this channel quickly inactivates in a similar manner as CRACM2 with two fast inactivation time courses [17, 18, 20] ; however, it appears that the second phase of fast inactivation is partially masked by a slower wave of reactivation. This reactivation is most pronounced at the more negative voltage pulses and appears to be both Ca 2+ and voltage dependent, as it was significantly attenuated, but not abolished, when exposing cells to DVF solutions ( Figure S2B ). In the absence of Ca 2+ , both CRACM1 and CRACM3 currents still increase slightly, probably because of voltage-dependent facilitation. The slow inactivation of CRACM1 currents is not obvious in the recordings shown in Figure 2D because it occurs over tens of seconds (see Figure 2A) . However, slow inactivation is reflected by the lower initial current amplitudes induced by the most negative pulses.
To assess the slow Ca 2+ -dependent inactivation of CRAC currents quantitatively, we perfused cells with 20 mM BAPTA and appropriate amounts of CaCl 2 so that free [Ca 2+ ] i was clamped to defined levels between 0 and 1 mM. Figure 3A shows that [Ca 2+ ] i dose-dependently inhibited CRACM1 currents but had little or no significant effect on CRACM2 or CRACM3 ( Figures 3B  and 3C ). The absence of significant slow inactivation seen with CRACM2 or CRACM3 is likely to be of some importance in the physiological context because intermediate [Ca 2+ ] i levels occurring physiologically (300-500 nM) would tend to maintain activity of CRACM2 and CRACM3 channels, whereas CRACM1 currents would be significantly reduced. Only at 1 mM [Ca 2+ ] i were the CRACM2 and CRACM3 currents suppressed almost as strongly as those carried by CRACM1. It remains to be determined whether the inhibitory effect seen at this high concentration reflects direct channel inhibition, is due to decreased coupling of STIM1 and CRACM proteins, or is caused by decreased IP 3 efficacy and refilling of stores.
We also examined the effect of [Ca 2+ ] i on the kinetics of CRAC-current activation by determining the time to half-maximal activation (t 1/2 ). We found this parameter to be predominantly independent of [Ca 2+ ] i for CRACM2 and CRACM1, which both had similarly fast activation kinetics ( Figure 3E Figure 3F ). Although CRACM1 is capable of generating 3-fold larger currents compared to CRACM2 or CRACM3 when [Ca 2+ ] i is buffered to near zero (see Figure 1A ), all three homologs achieve similar absolute levels in [ Figure 3D ).
CRACM Homologs Differ in Selectivity
Previous work on CRACM1 has identified critical residues in three regions that affect selectivity of the channel. Glutamate residue 106 in transmembrane (TM) segment 1 [11, 5, 6] and glutamate residue 190 in TM 3 [11, 5] are thought to form a ring of negatively charged amino acids lining the pore of the channel. Both of these residues are conserved identically in all three CRACM homologs and are therefore unlikely to account for differential selectivity. However, we have previously identified a third region, located in the loop between TM 1 and TM 2, that affects selectivity of CRACM1 [5] . This region has three key aspartate residues (D110/D112/D114) that we have proposed to form a second ring of negative charges that coordinate a second Ca 2+ ion to the CRACM1 pore, and those residues differ in the three homologs (CRACM2: E110/ Q112/Q114; CRACM3: E110/D112/E114). We therefore analyzed and compared the selectivity profiles of all three proteins with respect to Ca 2+ , Ba 2+ , and Na + permeation ( Figure 4 ). In the presence of 10 mM extracellular Ca 2+ , all three homologs generated large inward currents at 280 mV ( Figure 4A ) and exhibited similar inwardly rectifying I/V relationships ( Figures 4B and 4C) . When removing extracellular Ca 2+ , inward currents were suppressed to the same degree in the three channel species (Figures 4A-4C ), demonstrating that they share similarly high Ca 2+ selectivity and discriminate against Na + ions as long as Mg 2+ ions (2 mM) are present.
We next tested whether the CRACM homologs might exhibit different selectivities for Ba 2+ ions. Figure 4D illustrates that equimolar substitution greatly reduces inward currents in CRACM1, suggesting that this protein can discriminate Ca 2+ ions against Ba 2+ . Remarkably, in cells overexpressing CRACM2 or CRACM3, there remains significantly more inward current when Ba 2+ is used as charge carrier, and this finding at first glance would indicate higher Ba 2+ permeation. However, because Na + ions remain present in the extracellular solution, there is also the possibility that Na + might contribute to inward current when Ba 2+ is present. Indeed, when performing the same experiments as in Figure 4D , but additionally replacing Na + with TEA, the inward currents through all three homologs were essentially abolished ( Figure 4E) ; this indicated that Na + ions or a mixture of Na + and Ba 2+ may be carrying the current seen in Figure 4D . Native CRAC currents in Jurkat T cells and RBL cells have been considered to carry Ba 2+ ions [23, 18] ; however, this was determined in solutions in which both Na + and Ba 2+ were present. We re-examined Ba 2+ permeation in Jurkat T cells by replacing 10 mM Ca 2+ equimolarly with Ba 2+ in the presence and absence of Na + and find that significant inward currents through native CRAC channels are only recorded when both ions are present and are absent when Ba 2+ is used as the sole charge carrier (see Figure S3) .
To further assess the selectivity of CRACM channels, we tested for possible differences in Na + permeation in divalent-free solutions and 10 mM EDTA. Under these conditions, CRAC channels become permeable to Na + [17] , thus typically generating a 2-fold increase in inward current in HEK293 cells overexpressing CRACM1 (Figure 4F) . The fact that the same experimental protocol produces slightly larger CRACM2 currents, whereas CRACM3 generates a significantly larger monovalent current again suggests that CRACM homologs exhibit slightly different selectivities for Na + ions. Although mutational analysis is required to identify the contributions of the amino acid residues responsible for these differences, it seems likely that the 110/112/114 residues may be involved because those have been determined to contribute to monovalent permeation [5] and they are different in the three homologs.
CRACM Homologs Differ in Pharmacology
Finally, we tested for pharmacological differences between the CRACM homologs. 2-APB has been found to potentiate CRAC currents at low concentrations (%5 mM) and inhibit them at high concentrations (R10 mM) [24] [25] [26] . We previously demonstrated that CRACM1 is indeed completely inhibited by 50 mM 2-APB [8] (see Figure 4G ). However, CRACM2 appears to be significantly less sensitive because the same concentration reduced the current only by approximately 50%. The most striking effect, however, was observed with CRACM3, which was not inhibited at all and instead greatly potentiated by 50 mM 2-APB. Although the mechanism of action of 2-APB remains unknown and it cannot be considered a specific pharmacological tool for CRAC channels, the compound clearly has differential effects on the three homologs. If these effects also apply to native CRACM homomeric channels, it may currently represent the best pharmacological tool to identify endogenous CRAC-channel species expressed in various cell types.
In summary, our data present a comprehensive characterization of the three CRACM channels and reveal distinct biophysical properties such as activation kinetics, selectivity, Ca 2+ -dependent inactivation, and pharmacology (Table 1) . Finally, we demonstrate that the three homologs can form heteromeric channel complexes that may endow cells to express tailor-made CRAC channels for specific Ca 2+ signaling needs. The specific properties of CRACM channels described here may serve as a reference for future studies aimed at classifying the CRAC-channel composition of native cell types as well as guidance for site-directedmutagenesis studies designed to localize the sites responsible for the differences in functional and pharmacological properties of the CRACM channels.
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